BRUKER CORPORATION Restricted Cash and Cash Equivalents
BRUKER CORPORATION (BRKR) had Restricted Cash and Cash Equivalents of $4.20 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2026-08-05
- 2026-06-30: Restricted Cash and Cash Equivalents $4.20M.
- 2026-03-31: Restricted Cash and Cash Equivalents $4.20M.
- 2025-12-31: Restricted Cash and Cash Equivalents $4.30M.
- 2025-09-30: Restricted Cash and Cash Equivalents $4.20M.
| Period end | Restricted Cash and Cash Equivalents | Restricted Cash and Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $4.20M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $4.20M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $4.30M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $4.20M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $4.20M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $3.50M 10-Q · filed 2026-05-07 | |
| 2024-12-31 | $3.30M 10-Q · filed 2026-08-05 | |
| 2024-09-30 | $3.60M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $3.50M 10-Q · filed 2025-08-06 | |
| 2024-03-31 | $3.20M 10-Q · filed 2025-05-07 | |
| 2023-12-31 | $3.30M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $3.30M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $3.40M 10-Q · filed 2024-08-09 | |
| 2023-03-31 | $3.50M 10-Q · filed 2024-05-10 | |
| 2022-12-31 | $3.20M 10-K · filed 2026-02-27 | |
| 2022-09-30 | $3.10M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $3.30M 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $3.50M 10-Q · filed 2023-05-10 | |
| 2021-12-31 | $3.50M 10-K · filed 2025-03-03 | |
| 2021-09-30 | $3.50M 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $3.60M 10-Q · filed 2022-08-05 | |
| 2021-03-31 | $3.60M 10-Q · filed 2022-05-06 | |
| 2020-12-31 | $3.70M 10-K · filed 2024-02-29 | |
| 2020-09-30 | $3.50M 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $3.60M 10-Q · filed 2021-08-05 | |
| 2020-03-31 | $3.40M 10-Q · filed 2021-05-10 | |
| 2019-12-31 | $3.60M 10-K · filed 2023-03-01 | |
| 2019-09-30 | $3.70M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $4.00M 10-Q · filed 2020-08-07 | |
| 2018-12-31 | $3.90M 10-K · filed 2022-02-28 | |
| 2018-09-30 | $4.70M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $3.80M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $4.10M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $3.90M 10-K · filed 2021-03-01 | $4.00M 10-Q · filed 2018-05-10 |
| 2013-12-31 | $6.70M 10-K · filed 2014-02-27 | |
| 2012-12-31 | $7.60M 10-K · filed 2014-02-27 | |
| 2011-12-31 | $6.10M 10-K · filed 2013-02-28 | |
| 2010-12-31 | $6.40M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |